UK households using GLP-1 drugs (medicines that mimic a gut hormone) spent more than £1 billion less on groceries than expected in the year after adoption than comparable non-user households, Worldpanel by Numerator said. The share of British households with at least one user rose from 6.3% in February to 8.5% in August, with pills accounting for 11.2% of users despite regulatory approval arriving only in June. Men represented 32% of users, up from 23% in February. The displaced grocery spending equates to £389 a year per user household, while alcohol and crisps spending fell 15% more than among non-user households. Frozen ready-meal volume sales rose 30% among users. Worldpanel said its estimates indicated GLP-1 use could exceed 10% of British households in 2027.